Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study

We sequentially assessed the presence of SARS-CoV-2 IgG antibodies in 1253 hospital workers including 1026 HCWs at the University Medical Center Hamburg-Eppendorf at three time points during the early phase of the epidemic. By the end of the study in July 2020, the overall seroprevalence was 1.8% (n...

Descripción completa

Detalles Bibliográficos
Autores principales: Brehm, Thomas Theo, Schwinge, Dorothee, Lampalzer, Sibylle, Schlicker, Veronika, Küchen, Julia, Thompson, Michelle, Ullrich, Felix, Huber, Samuel, Schmiedel, Stefan, Addo, Marylyn M., Lütgehetmann, Marc, Knobloch, Johannes K., Schulze zur Wiesch, Julian, Lohse, Ansgar W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier GmbH. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832715/
https://www.ncbi.nlm.nih.gov/pubmed/33338782
http://dx.doi.org/10.1016/j.ijheh.2020.113671
_version_ 1783641897203400704
author Brehm, Thomas Theo
Schwinge, Dorothee
Lampalzer, Sibylle
Schlicker, Veronika
Küchen, Julia
Thompson, Michelle
Ullrich, Felix
Huber, Samuel
Schmiedel, Stefan
Addo, Marylyn M.
Lütgehetmann, Marc
Knobloch, Johannes K.
Schulze zur Wiesch, Julian
Lohse, Ansgar W.
author_facet Brehm, Thomas Theo
Schwinge, Dorothee
Lampalzer, Sibylle
Schlicker, Veronika
Küchen, Julia
Thompson, Michelle
Ullrich, Felix
Huber, Samuel
Schmiedel, Stefan
Addo, Marylyn M.
Lütgehetmann, Marc
Knobloch, Johannes K.
Schulze zur Wiesch, Julian
Lohse, Ansgar W.
author_sort Brehm, Thomas Theo
collection PubMed
description We sequentially assessed the presence of SARS-CoV-2 IgG antibodies in 1253 hospital workers including 1026 HCWs at the University Medical Center Hamburg-Eppendorf at three time points during the early phase of the epidemic. By the end of the study in July 2020, the overall seroprevalence was 1.8% (n = 22), indicating the overall effectiveness of infection control interventions in mitigating coronavirus disease 2019 (COVID-19) in hospital workers.
format Online
Article
Text
id pubmed-7832715
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier GmbH.
record_format MEDLINE/PubMed
spelling pubmed-78327152021-01-26 Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study Brehm, Thomas Theo Schwinge, Dorothee Lampalzer, Sibylle Schlicker, Veronika Küchen, Julia Thompson, Michelle Ullrich, Felix Huber, Samuel Schmiedel, Stefan Addo, Marylyn M. Lütgehetmann, Marc Knobloch, Johannes K. Schulze zur Wiesch, Julian Lohse, Ansgar W. Int J Hyg Environ Health Article We sequentially assessed the presence of SARS-CoV-2 IgG antibodies in 1253 hospital workers including 1026 HCWs at the University Medical Center Hamburg-Eppendorf at three time points during the early phase of the epidemic. By the end of the study in July 2020, the overall seroprevalence was 1.8% (n = 22), indicating the overall effectiveness of infection control interventions in mitigating coronavirus disease 2019 (COVID-19) in hospital workers. Elsevier GmbH. 2021-03 2020-11-30 /pmc/articles/PMC7832715/ /pubmed/33338782 http://dx.doi.org/10.1016/j.ijheh.2020.113671 Text en © 2020 Elsevier GmbH. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Brehm, Thomas Theo
Schwinge, Dorothee
Lampalzer, Sibylle
Schlicker, Veronika
Küchen, Julia
Thompson, Michelle
Ullrich, Felix
Huber, Samuel
Schmiedel, Stefan
Addo, Marylyn M.
Lütgehetmann, Marc
Knobloch, Johannes K.
Schulze zur Wiesch, Julian
Lohse, Ansgar W.
Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
title Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
title_full Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
title_fullStr Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
title_full_unstemmed Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
title_short Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study
title_sort seroprevalence of sars-cov-2 antibodies among hospital workers in a german tertiary care center: a sequential follow-up study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832715/
https://www.ncbi.nlm.nih.gov/pubmed/33338782
http://dx.doi.org/10.1016/j.ijheh.2020.113671
work_keys_str_mv AT brehmthomastheo seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT schwingedorothee seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT lampalzersibylle seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT schlickerveronika seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT kuchenjulia seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT thompsonmichelle seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT ullrichfelix seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT hubersamuel seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT schmiedelstefan seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT addomarylynm seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT lutgehetmannmarc seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT knoblochjohannesk seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT schulzezurwieschjulian seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy
AT lohseansgarw seroprevalenceofsarscov2antibodiesamonghospitalworkersinagermantertiarycarecenterasequentialfollowupstudy

Ejemplares similares